{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T23:20:20Z","timestamp":1793834420758,"version":"4.6.1"},"reference-count":159,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T00:00:00Z","timestamp":1783296000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>\n                    Coronary artery disease (CAD) remains the leading cause of cardiovascular mortality worldwide and shows a strong age-dependence that classical risk-factor models do not fully explain. A growing body of work indicates that aging is closely associated with CAD and, in preclinical models, can promote it through immunometabolic remodeling of the gut\u2013liver\u2013heart axis, in which bile acid metabolism is proposed to act as a central molecular link. Here we integrate cellular, molecular, and clinical evidence to outline how aging perturbs this axis and sustains chronic vascular inflammation. At the cellular level, senescent cells in the intestinal, hepatic, and vascular compartments generate the senescence-associated secretory phenotype (SASP) \u2014 a process linked to cGAS\u2013STING and NLRP3 inflammasome activation, mitochondrial dysfunction, and decline of the NAD\n                    <jats:sup>+<\/jats:sup>\n                    \u2013SIRT3 axis \u2014 and help establish the systemic state of inflammaging. In the gut, age-related dysbiosis lowers bile salt hydrolase and 7\u03b1-dehydroxylase activities, contracts the secondary bile acid pool, weakens epithelial barrier integrity, and triggers metabolic endotoxemia that maintains LPS\u2013TLR4\u2013NF-\u03baB signaling. In the liver, Kupffer cell M1 polarization, attenuated farnesoid X receptor (FXR) signaling, and altered exosomal cargo amplify systemic inflammatory output. Reduced FXR and Takeda G-protein-coupled receptor 5 (TGR5) signaling weakens the endogenous restraint of macrophage activation, vascular smooth muscle cell phenotypic switching, and cardiomyocyte metabolic protection. The downstream result is endothelial dysfunction, foam cell formation, plaque instability, and adverse cardiac remodeling. We then appraise emerging immune\u2013metabolic interventions \u2014 microbiota remodeling, FXR\/TGR5 agonists, senolytic therapies, metformin, and integrated biomarker frameworks for early risk stratification \u2014 while noting that most are currently supported only by preclinical or early-phase human data. By placing bile acid signaling at the interface of innate immunity, microbial ecology, and metabolic homeostasis, this review offers an immunological framework for aging-associated CAD and identifies candidate immune-metabolic targets for prevention and therapy in older adults.\n                  <\/jats:p>","DOI":"10.3389\/fimmu.2026.1870980","type":"journal-article","created":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T04:21:10Z","timestamp":1783311670000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Aging-driven metabolic abnormalities remodel intercellular communication through the gut\u2013liver\u2013heart axis and may promote coronary artery disease: the key role of bile acid metabolism"],"prefix":"10.3389","volume":"17","author":[{"given":"Wei","family":"Chen","sequence":"first","affiliation":[{"name":"Liaoning University of Traditional Chinese Medicine","place":["Shenyang, China"]},{"name":"Affiliated Hospital of Liaoning University of Traditional Chinese Medicine","place":["Shenyang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Sun","sequence":"additional","affiliation":[{"name":"Liaoning University of Traditional Chinese Medicine","place":["Shenyang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chu-fan","family":"Meng","sequence":"additional","affiliation":[{"name":"Liaoning University of Traditional Chinese Medicine","place":["Shenyang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Si-tong","family":"Wu","sequence":"additional","affiliation":[{"name":"Liaoning University of Traditional Chinese Medicine","place":["Shenyang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin-yi","family":"Jiang","sequence":"additional","affiliation":[{"name":"Liaoning University of Traditional Chinese Medicine","place":["Shenyang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xian-meng","family":"Meng","sequence":"additional","affiliation":[{"name":"Affiliated Hospital of Liaoning University of Traditional Chinese Medicine","place":["Shenyang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing-feng","family":"Wang","sequence":"additional","affiliation":[{"name":"Liaoning University of Traditional Chinese Medicine","place":["Shenyang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,7,6]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"2982","DOI":"10.1016\/j.jacc.2020.11.010","article-title":"Global burden of cardiovascular diseases and risk factors, 1990\u20132019: update from the GBD 2019 study","volume":"76","author":"Roth","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1161\/cir.0000000000001052","article-title":"Heart disease and stroke statistics\u20142022 update: a report from the American Heart Association","volume":"145","author":"Tsao","year":"2022","journal-title":"Circulation"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacbts.2023.12.003","article-title":"Cellular senescence as a targetable risk factor for cardiovascular diseases: therapeutic implications: JACC family series","volume":"9","author":"Kumar","year":"2024","journal-title":"Basic to Trans Sci"},{"key":"B4","doi-asserted-by":"publisher","first-page":"16","DOI":"10.20517\/jca.2023.45","article-title":"Targeting vascular senescence in cardiovascular disease with aging","volume":"4","author":"Hall","year":"2024","journal-title":"J Cardiovasc Aging"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2022.11.001","article-title":"Hallmarks of aging: An expanding universe","volume":"186","author":"L\u00f3pez-Ot\u00edn","year":"2023","journal-title":"Cell"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1161\/circresaha.120.316242","article-title":"Gut microbiota and cardiovascular disease","volume":"127","author":"Witkowski","year":"2020","journal-title":"Circ Res"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1002\/dmrr.70167","article-title":"Intersecting molecular pathways in cardiovascular disease and diabetes mellitus: Emerging roles of inflammation and therapeutics","volume":"42","author":"Anagnostopoulou","year":"2026","journal-title":"Diabetes Metab Res Rev"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3390\/ijms251910595","article-title":"Non-alcoholic fatty liver disease and coronary artery disease: A bidirectional association based on endothelial dysfunction","volume":"25","author":"Ktenopoulos","year":"2024","journal-title":"Int J Mol Sci"},{"key":"B9","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s40168-020-00821-0","article-title":"Gut microbiota and cardiovascular disease: opportunities and challenges","volume":"8","author":"Kazemian","year":"2020","journal-title":"Microbiome"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1038\/s42255-021-00348-0","article-title":"Gut microbiome pattern reflects healthy ageing and predicts survival in humans","volume":"3","author":"Wilmanski","year":"2021","journal-title":"Nat Metab"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.apsb.2021.12.011","article-title":"Bile acid coordinates microbiota homeostasis and systemic immunometabolism in cardiometabolic diseases","volume":"12","author":"Guan","year":"2022","journal-title":"Acta Pharm Sin B"},{"key":"B12","doi-asserted-by":"publisher","first-page":"261","DOI":"10.14336\/ad.2022.0817","article-title":"The role of bile acids in cardiovascular diseases: from mechanisms to clinical implications","volume":"14","author":"Zhang","year":"2023","journal-title":"Aging Dis"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1152\/ajpgi.00223.2019","article-title":"Bile acid receptors FXR and TGR5 signaling in fatty liver diseases and therapy","volume":"318","author":"Chiang","year":"2020","journal-title":"Am J Physiology-Gastrointestinal Liver Physiol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1152\/physrev.00049.2019","article-title":"Molecular physiology of bile acid signaling in health, disease, and aging","volume":"101","author":"Perino","year":"2021","journal-title":"Physiol Rev"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1038\/s41579-022-00805-x","article-title":"Bile acids and the gut microbiota: metabolic interactions and impacts on disease","volume":"21","author":"Collins","year":"2023","journal-title":"Nat Rev Microbiol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1097\/md.0000000000035795","article-title":"The role of the gut microbiota and bile acids in heart failure: A review","volume":"102","author":"Shi","year":"2023","journal-title":"Medicine"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1038\/s44318-025-00601-2","article-title":"Distinct senotypes in p16- and p21-positive cells across human and mouse aging tissues","volume":"44","author":"Saul","year":"2025","journal-title":"EMBO J"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3390\/cells12010106","article-title":"Senescence-associated secretory phenotype of cardiovascular system cells and inflammaging: perspectives of peptide regulation","volume":"12","author":"Khavinson","year":"2022","journal-title":"Cells"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1111\/imr.70084","article-title":"Cellular senescence, inflammaging and cardiovascular disease","volume":"337","author":"Zanders","year":"2026","journal-title":"Immunol Rev"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1132653","article-title":"cGAS-STING pathway as a potential trigger of immunosenescence and inflammaging","volume":"14","author":"Schmitz","year":"2023","journal-title":"Front Immunol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.14336\/ad.2023.0117","article-title":"The role of cGAS-STING in age-related diseases from mechanisms to therapies","volume":"14","author":"Zheng","year":"2023","journal-title":"Aging Dis"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1111\/cas.14266","article-title":"Cellular senescence and senescence\u2010associated secretory phenotype via the cGAS\u2010STING signaling pathway in cancer","volume":"111","author":"Loo","year":"2020","journal-title":"Cancer Sci"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2022.07.004","article-title":"NF-\u03baB: blending metabolism, immunity, and inflammation","volume":"43","author":"Capece","year":"2022","journal-title":"Trends Immunol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.14336\/ad.2022.0417","article-title":"cGAS-STING pathway performance in the vulnerable atherosclerotic plaque","volume":"13","author":"Wan","year":"2022","journal-title":"Aging Dis"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.00632.2023","article-title":"Cardiovascular aging: spotlight on mitochondria","volume":"326","author":"Ali","year":"2024","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2025.124127","article-title":"Mitochondria at the crossroads of aging and cardiovascular disease","volume":"385","author":"Lateef","year":"2026","journal-title":"Life Sci"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.20517\/jca.2023.09","article-title":"Cardiovascular aging: from cellular and molecular changes to therapeutic interventions","volume":"3","author":"Vakka","year":"2023","journal-title":"J Cardiovasc Aging"},{"key":"B28","doi-asserted-by":"publisher","first-page":"2575","DOI":"10.14336\/ad.2024.0058","article-title":"Mitochondrial dysfunction: a roadmap for understanding and tackling cardiovascular aging","volume":"16","author":"Zhang","year":"2024","journal-title":"Aging Dis"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-022-00760-x","article-title":"Mitochondrial control of inflammation","volume":"23","author":"Marchi","year":"2023","journal-title":"Nat Rev Immunol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.3390\/antiox11020269","article-title":"NLRP3 inflammasome in vascular disease: a recurrent villain to combat pharmacologically","volume":"11","author":"Gonz\u00e1lez-Moro","year":"2022","journal-title":"Antioxidants"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1550226","article-title":"NLRP3 inflammasome in cardiovascular diseases: an update","volume":"16","author":"Mo","year":"2025","journal-title":"Front Immunol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2022.882211","article-title":"Modern concepts in cardiovascular disease: inflamm-aging","volume":"10","author":"Puspitasari","year":"2022","journal-title":"Front Cell Dev Biol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"33","DOI":"10.20517\/jca.2023.22","article-title":"Cardiovascular aging: the mitochondrial influence","volume":"3","author":"Sagar","year":"2023","journal-title":"J Cardiovasc Aging"},{"key":"B34","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1038\/s41392-025-02253-4","article-title":"Mitochondria in oxidative stress, inflammation and aging: from mechanisms to therapeutic advances","volume":"10","author":"Xu","year":"2025","journal-title":"Signal Transduction Targeted Ther"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines9111574","article-title":"Sirtuin 3 (SIRT3) pathways in age-related cardiovascular and neurodegenerative diseases","volume":"9","author":"Silaghi","year":"2021","journal-title":"Biomedicines"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1007\/s10741-023-10295-5","article-title":"Changes of energy metabolism in failing heart and its regulation by SIRT3","volume":"28","author":"Wang","year":"2023","journal-title":"Heart Failure Rev"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1007\/s11357-022-00695-0","article-title":"The loss of cardiac SIRT3 decreases metabolic flexibility and proteostasis in an age-dependent manner","volume":"45","author":"Li","year":"2023","journal-title":"Geroscience"},{"key":"B38","doi-asserted-by":"crossref","DOI":"10.1007\/978-981-16-7977-3_8","article-title":"NAD+ metabolism in aging","volume-title":"Aging Mechanisms II","author":"Palikhe","year":"2022"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1210\/endrev\/bnab037","article-title":"A modern approach to dyslipidemia","volume":"43","author":"Berberich","year":"2022","journal-title":"Endocr Rev"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1093\/clinchem\/hvaa252","article-title":"Residual cardiovascular risk at low LDL: remnants, lipoprotein (a), and inflammation","volume":"67","author":"Hoogeveen","year":"2021","journal-title":"Clin Chem"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1097\/mol.0000000000000824","article-title":"Small dense low-density lipoprotein particles: clinically relevant","volume":"33","author":"Krauss","year":"2022","journal-title":"Curr Opin Lipidology"},{"key":"B42","doi-asserted-by":"publisher","first-page":"15","DOI":"10.4093\/dmj.2021.0280","article-title":"Insulin resistance: from mechanisms to therapeutic strategies","volume":"46","author":"Lee","year":"2022","journal-title":"Diabetes Metab J"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1038\/s41575-020-00404-2","article-title":"The role of farnesoid X receptor in metabolic diseases, and gastrointestinal and liver cancer","volume":"18","author":"Sun","year":"2021","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2024.1447878","article-title":"Regulation of bile acids and their receptor FXR in metabolic diseases","volume":"11","author":"Li","year":"2024","journal-title":"Front Nutr"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.768560","article-title":"Kynurenine pathway metabolites as potential clinical biomarkers in coronary artery disease","volume":"12","author":"G\u00e1sp\u00e1r","year":"2022","journal-title":"Front Immunol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2024.1406856","article-title":"The role of the kynurenine pathway in cardiovascular disease","volume":"11","author":"Yang","year":"2024","journal-title":"Front Cardiovasc Med"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1177\/11786469221096643","article-title":"The footprint of kynurenine pathway in cardiovascular diseases","volume":"15","author":"Ala","year":"2022","journal-title":"Int J Tryptophan Res"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2026.1726522","article-title":"The tryptophan-kynurenine pathway in cardiovascular diseases: mechanistic insights and therapeutic opportunities","volume":"13","author":"Chen","year":"2026","journal-title":"Front Cardiovasc Med"},{"key":"B49","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/s41575-024-00914-3","article-title":"The changing metabolic landscape of bile acids\u2013keys to metabolism and immune regulation","volume":"21","author":"Mohanty","year":"2024","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B50","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s43556-022-00091-2","article-title":"The role of the gut microbiota in health and cardiovascular diseases","volume":"3","author":"Wang","year":"2022","journal-title":"Mol BioMed"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1111\/acel.14315","article-title":"The connection between aging, cellular senescence and gut microbiome alterations: A comprehensive review","volume":"23","author":"Jang","year":"2024","journal-title":"Aging Cell"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1111\/acel.13700","article-title":"A gut\u2010centric view of aging: Do intestinal epithelial cells contribute to age\u2010associated microbiota changes, inflammaging, and immunosenescence","volume":"21","author":"Hohman","year":"2022","journal-title":"Aging Cell"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.3390\/nu15081850","article-title":"Emerging roles of gut microbial modulation of bile acid composition in the etiology of cardiovascular diseases","volume":"15","author":"Yntema","year":"2023","journal-title":"Nutrients"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2025.1513541","article-title":"New insights into microbial bile salt hydrolases: From physiological roles to potential applications","volume":"16","author":"Dong","year":"2025","journal-title":"Front Microbiol"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.3390\/bioengineering10080935","article-title":"Peripheral vascular disease and carotid artery disease are associated with decreased bile acid excretion","volume":"10","author":"Charach","year":"2023","journal-title":"Bioengineering"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajpath.2023.06.007","article-title":"The role of gut microbiome-derived short-chain fatty acid butyrate in hepatobiliary diseases","volume":"193","author":"Pant","year":"2023","journal-title":"Am J Pathol"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2024.2393270","article-title":"The interplay between gut microbiota, short-chain fatty acids, and implications for host health and disease","volume":"16","author":"Hays","year":"2024","journal-title":"Gut Microbes"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2022.101706","article-title":"Short-chain fatty acid metabolism and multiple effects on cardiovascular diseases","volume":"81","author":"Hu","year":"2022","journal-title":"Ageing Res Rev"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1007\/s11739-023-03374-w","article-title":"Gut microbiota, intestinal permeability, and systemic inflammation: a narrative review","volume":"19","author":"Di Vincenzo","year":"2024","journal-title":"Internal Emergency Med"},{"key":"B60","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/s41536-022-00226-7","article-title":"Intestinal stem cell aging signature reveals a reprogramming strategy to enhance regenerative potential","volume":"7","author":"Nefzger","year":"2022","journal-title":"NPJ Regener Med"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1093\/gerona\/glae045","article-title":"Intestinal permeability, gut inflammation, and gut immune system response are linked to aging-related changes in gut microbiota composition: a study in female mice","volume":"79","author":"G\u00e1mez-Mac\u00edas","year":"2024","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.33963\/kp.a2023.0115","article-title":"Gut dysbiosis-derived low-grade endotoxemia: A common basis for liver and cardiovascular disease","volume":"81","author":"Violi","year":"2023","journal-title":"Polish Heart J (Kardiologia Polska)"},{"key":"B63","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/s12979-023-00383-3","article-title":"Toll-like receptor 4 (TLR4): new insight immune and aging","volume":"20","author":"Kim","year":"2023","journal-title":"Immun Ageing"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1021\/acsomega.4c02999","article-title":"Determination of site-specific phosphorylation occupancy using targeted mass spectrometry reveals the regulation of human apical bile acid transporter, ASBT","volume":"9","author":"Nguyen","year":"2024","journal-title":"ACS Omega"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2022.108238","article-title":"Bile acid metabolism and signaling, the microbiota, and metabolic disease","volume":"237","author":"Cai","year":"2022","journal-title":"Pharmacol Ther"},{"key":"B66","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1186\/s40168-023-01709-5","article-title":"Gut microbiota-bile acid crosstalk regulates murine lipid metabolism via the intestinal FXR-FGF19 axis in diet-induced humanized dyslipidemia","volume":"11","author":"Xu","year":"2023","journal-title":"Microbiome"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2025.1607899","article-title":"Bile acids affect intestinal barrier function through FXR and TGR5","volume":"12","author":"Song","year":"2025","journal-title":"Front Med"},{"key":"B68","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1038\/s44161-025-00637-x","article-title":"The gut microbiota\u2013bile acid\u2013TGR5 axis orchestrates platelet activation and atherothrombosis","volume":"4","author":"Qi","year":"2025","journal-title":"Nat Cardiovasc Res"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1002\/path.6193","article-title":"A new FGF15\/19-mediated gut-to-heart axis controls cardiac hypertrophy","volume":"261","author":"Mor\u00f3n-Ros","year":"2023","journal-title":"J Pathol"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajcnut.2024.02.019","article-title":"Changes in bile acid subtypes and improvements in lipid metabolism and atherosclerotic cardiovascular disease risk: the Preventing Overweight Using Novel Dietary Strategies (POUNDS Lost) trial","volume":"119","author":"Heianza","year":"2024","journal-title":"Am J Clin Nutr"},{"key":"B71","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.livres.2020.05.001","article-title":"Up to date on cholesterol 7 alpha-hydroxylase (CYP7A1) in bile acid synthesis","volume":"4","author":"Chiang","year":"2020","journal-title":"Liver Res"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1007\/s11357-024-01137-9","article-title":"Genome-wide analysis of hepatic DNA methylation reveals impact of epigenetic aging on xenobiotic metabolism and transport genes in an aged mouse model","volume":"46","author":"Abudahab","year":"2024","journal-title":"Geroscience"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1038\/s41401-021-00849-4","article-title":"FXR: structures, biology, and drug development for NASH and fibrosis diseases","volume":"43","author":"Tian","year":"2022","journal-title":"Acta Pharmacol Sin"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1111\/acel.13811","article-title":"Age-dependent loss of hepatic SIRT1 enhances NLRP3 inflammasome signaling and impairs capacity for liver fibrosis resolution","volume":"22","author":"Adjei-Mosi","year":"2023","journal-title":"Aging Cell"},{"key":"B75","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.14336\/ad.2023.0830","article-title":"Farnesoid X receptor: from structure to function and its pharmacology in liver fibrosis","volume":"15","author":"Ding","year":"2024","journal-title":"Aging Dis"},{"key":"B76","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s40364-023-00458-9","article-title":"The essential roles of FXR in diet and age influenced metabolic changes and liver disease development: a multi-omics study","volume":"11","author":"Yang","year":"2023","journal-title":"biomark Res"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v30.i7.652","article-title":"Recent advances in age-related metabolic dysfunction-associated steatotic liver disease","volume":"30","author":"He","year":"2024","journal-title":"World J Gastroenterol"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2024.122544","article-title":"Exosomes based strategies for cardiovascular diseases: opportunities and challenges","volume":"308","author":"Li","year":"2024","journal-title":"Biomaterials"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2021.108025","article-title":"Extracellular vesicles in cardiovascular disease: Biological functions and therapeutic implications","volume":"233","author":"Han","year":"2022","journal-title":"Pharmacol Ther"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1016\/j.plipres.2021.101094","article-title":"Bile acids and their receptors in metabolic disorders","volume":"82","author":"Fiorucci","year":"2021","journal-title":"Prog Lipid Res"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2013.12.003","article-title":"Hepatic steatosis exacerbated by endoplasmic reticulum stress-mediated downregulation of FXR in aging mice","volume":"60","author":"Xiong","year":"2014","journal-title":"J Hepatol"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2025.1493662","article-title":"Takeda G protein\u2013coupled receptor 5 (TGR5): an attractive therapeutic target for aging-related cardiovascular diseases","volume":"16","author":"He","year":"2025","journal-title":"Front Pharmacol"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2019.09.010","article-title":"Glucagon-like peptide 1 (GLP-1)","volume":"30","author":"M\u00fcller","year":"2019","journal-title":"Mol Metab"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1038\/s42255-024-01036-5","article-title":"Inhibition of fatty acid uptake by TGR5 prevents diabetic cardiomyopathy","volume":"6","author":"Wang","year":"2024","journal-title":"Nat Metab"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1042\/bsr20193482","article-title":"Overexpression of TGR5 alleviates myocardial ischemia\/reperfusion injury via AKT\/GSK-3\u03b2 mediated inflammation and mitochondrial pathway","volume":"40","author":"Li","year":"2020","journal-title":"Biosci Rep"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1161\/atvbaha.113.301565","article-title":"Bile acid receptor TGR5 agonism induces NO production and reduces monocyte adhesion in vascular endothelial cells","volume":"33","author":"Kida","year":"2013","journal-title":"Arteriosclerosis Thrombosis Vasc Biol"},{"key":"B87","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1038\/s41467-025-56885-9","article-title":"FGF21 protects against HFpEF by improving cardiac mitochondrial bioenergetics in mice","volume":"16","author":"Zhang","year":"2025","journal-title":"Nat Commun"},{"key":"B88","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1038\/s41419-023-05842-9","article-title":"FGF21-FGFR1 controls mitochondrial homeostasis in cardiomyocytes by modulating the degradation of OPA1","volume":"14","author":"Yan","year":"2023","journal-title":"Cell Death Dis"},{"key":"B89","doi-asserted-by":"publisher","first-page":"2019","DOI":"10.1038\/ncomms3019","article-title":"Fibroblast growth factor 21 protects against cardiac hypertrophy in mice","volume":"4","author":"Planavila","year":"2013","journal-title":"Nat Commun"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.34067\/kid.0007502020","article-title":"Free deoxycholic acid exacerbates vascular calcification in CKD through ER stress-mediated ATF4 activation","volume":"2","author":"Miyazaki-Anzai","year":"2021","journal-title":"Kidney360"},{"key":"B91","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1053\/j.ajkd.2017.06.017","article-title":"Deoxycholic acid, a metabolite of circulating bile acids, and coronary artery vascular calcification in CKD","volume":"71","author":"Jovanovich","year":"2018","journal-title":"Am J Kidney Dis"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.3177\/jnsv.60.450","article-title":"Deoxycholic acid is involved in the proliferation and migration of vascular smooth muscle cells","volume":"60","author":"Shimizu","year":"2014","journal-title":"J Nutr Sci Vitaminology"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.3390\/cells8121471","article-title":"Tauroursodeoxycholate\u2014bile acid with chaperoning activity: molecular and cellular effects and therapeutic perspectives","volume":"8","author":"Kusaczuk","year":"2019","journal-title":"Cells"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.25742","article-title":"TUDCA: An agonist of the bile acid receptor GPBAR1\/TGR5 with anti\u2010inflammatory effects in microglial cells","volume":"232","author":"Yanguas\u2010Cas\u00e1s","year":"2017","journal-title":"J Cell Physiol"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2020.601349","article-title":"FGF19 and FGF21 for the treatment of NASH\u2014two sides of the same coin? Differential and overlapping effects of FGF19 and FGF21 from mice to human","volume":"11","author":"Henriksson","year":"2020","journal-title":"Front Endocrinol"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-021-03392-8","article-title":"The changing landscape of atherosclerosis","volume":"592","author":"Libby","year":"2021","journal-title":"Nature"},{"key":"B97","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s11658-023-00423-2","article-title":"Endothelial dysfunction due to eNOS uncoupling: molecular mechanisms as potential therapeutic targets","volume":"28","author":"Janaszak-Jasiecka","year":"2023","journal-title":"Cell Mol Biol Lett"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1111\/jgh.15509","article-title":"Deoxycholic acid enhancement of lymphocyte migration through direct interaction with the intestinal vascular endothelium","volume":"36","author":"Shibuya","year":"2021","journal-title":"J Gastroenterol Hepatol"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2022.04.004","article-title":"Atherosclerosis: Recent developments","volume":"185","author":"Bj\u00f6rkegren","year":"2022","journal-title":"Cell"},{"key":"B100","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s13578-022-00815-5","article-title":"The multifaceted role of the SASP in atherosclerosis: from mechanisms to therapeutic opportunities","volume":"12","author":"Sun","year":"2022","journal-title":"Cell Bioscience"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1172\/jci82719","article-title":"Endothelial-to-mesenchymal transition drives atherosclerosis progression","volume":"125","author":"Chen","year":"2015","journal-title":"J Clin Invest"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/cvx253","article-title":"Endothelial\u2013mesenchymal transition in atherosclerosis","volume":"114","author":"Souilhol","year":"2018","journal-title":"Cardiovasc Res"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1161\/circulationaha.120.048378","article-title":"Single-cell genomics reveals a novel cell state during smooth muscle cell phenotypic switching and potential therapeutic targets for atherosclerosis in mouse and human","volume":"142","author":"Pan","year":"2020","journal-title":"Circulation"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/cvab046","article-title":"Vascular smooth muscle cells in atherosclerosis: time for a re-assessment","volume":"117","author":"Grootaert","year":"2021","journal-title":"Cardiovasc Res"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1161\/circulationaha.120.046672","article-title":"Stem cell pluripotency genes Klf4 and Oct4 regulate complex SMC phenotypic changes critical in late-stage atherosclerotic lesion pathogenesis","volume":"142","author":"Alencar","year":"2020","journal-title":"Circulation"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1038\/s41569-021-00624-2","article-title":"The role of cellular senescence in cardiac disease: basic biology and clinical relevance","volume":"19","author":"Mehdizadeh","year":"2022","journal-title":"Nat Rev Cardiol"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2022.06.453","article-title":"Autophagy is differentially regulated in leukocyte and nonleukocyte foam cells during atherosclerosis","volume":"130","author":"Robichaud","year":"2022","journal-title":"Circ Res"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1038\/s41569-019-0169-2","article-title":"Inflammation and its resolution in atherosclerosis: mediators and therapeutic opportunities","volume":"16","author":"B\u00e4ck","year":"2019","journal-title":"Nat Rev Cardiol"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.3390\/genes13050756","article-title":"Macrophage polarization in atherosclerosis","volume":"13","author":"Eshghjoo","year":"2022","journal-title":"Genes"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1350471","article-title":"Adaptive immunity and atherosclerosis: aging at its crossroads","volume":"15","author":"Snijckers","year":"2024","journal-title":"Front Immunol"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.609060","article-title":"TGR5 regulates macrophage inflammation in nonalcoholic steatohepatitis by modulating NLRP3 inflammasome activation","volume":"11","author":"Shi","year":"2021","journal-title":"Front Immunol"},{"key":"B112","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/s41392-022-00955-7","article-title":"Inflammation and atherosclerosis: signaling pathways and therapeutic intervention","volume":"7","author":"Kong","year":"2022","journal-title":"Signal Transduction Targeted Ther"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-019-0240-6","article-title":"Efferocytosis in health and disease","volume":"20","author":"Doran","year":"2020","journal-title":"Nat Rev Immunol"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2017.00086","article-title":"Mechanisms and consequences of defective efferocytosis in atherosclerosis","volume":"4","author":"Yurdagul","year":"2018","journal-title":"Front Cardiovasc Med"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1016\/b978-0-323-99991-5.00002-4","article-title":"Cardiac energy metabolism in heart failure","volume":"128","author":"Lopaschuk","year":"2021","journal-title":"Circ Res"},{"key":"B116","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1093\/cvr\/cvab120","article-title":"Concurrent diabetes and heart failure: interplay and novel therapeutic approaches","volume":"118","author":"Karwi","year":"2022","journal-title":"Cardiovasc Res"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.1161\/circresaha.118.310082","article-title":"Calcium signaling and reactive oxygen species in mitochondria","volume":"122","author":"Bertero","year":"2018","journal-title":"Circ Res"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2022.848214","article-title":"Mitochondrial dynamics, mitophagy, and mitochondria\u2013endoplasmic reticulum contact sites crosstalk under hypoxia","volume":"10","author":"Wang","year":"2022","journal-title":"Front Cell Dev Biol"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.1155\/2023\/4015199","article-title":"Cryptotanshinone attenuated pathological cardiac remodeling in vivo and in vitro experiments","volume":"2023","author":"Li","year":"2023","journal-title":"Oxid Med Cell Longev"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.1038\/s41569-020-0363-2","article-title":"Evaluation and management of heart failure with preserved ejection fraction","volume":"17","author":"Borlaug","year":"2020","journal-title":"Nat Rev Cardiol"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1126\/science.aau6977","article-title":"The biology, function, and biomedical applications of exosomes","volume":"367","author":"Kalluri","year":"2020","journal-title":"Science"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.1002\/jev2.12404","article-title":"Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches","volume":"13","author":"Welsh","year":"2024","journal-title":"J Extracell Vesicles"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.1161\/circresaha.113.300858","article-title":"Microvesicles as cell\u2013cell messengers in cardiovascular diseases","volume":"114","author":"Loyer","year":"2014","journal-title":"Circ Res"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.893617","article-title":"The potential role of gut microbial-derived exosomes in metabolic-associated fatty liver disease: Implications for treatment","volume":"13","author":"Zhang","year":"2022","journal-title":"Front Immunol"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.1080\/20013078.2018.1535750","article-title":"Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines","volume":"7","author":"Th\u00e9ry","year":"2018","journal-title":"J Extracell Vesicles"},{"key":"B126","doi-asserted-by":"publisher","first-page":"22661","DOI":"10.1038\/s41598-021-02144-y","article-title":"Circulating bile acids concentration is predictive of coronary artery disease in human","volume":"11","author":"Chong Nguyen","year":"2021","journal-title":"Sci Rep"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.3390\/nu16071062","article-title":"Bile acids and risk of adverse cardiovascular events and all-cause mortality in patients with acute coronary syndrome","volume":"16","author":"Mateu-Fabregat","year":"2024","journal-title":"Nutrients"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.1016\/j.cardfail.2017.06.007","article-title":"Increased secondary\/primary bile acid ratio in chronic heart failure","volume":"23","author":"Mayerhofer","year":"2017","journal-title":"J Cardiac Failure"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/cvae061","article-title":"Lactiplantibacillus plantarum strains KABP011, KABP012, and KABP013 modulate bile acids and cholesterol metabolism in humans","volume":"120","author":"Padro","year":"2024","journal-title":"Cardiovasc Res"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2019-319654","article-title":"Mediterranean diet intervention alters the gut microbiome in older people reducing frailty and improving health status: the NU-AGE 1-year dietary intervention across five European countries","volume":"69","author":"Ghosh","year":"2020","journal-title":"Gut"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2019.08.069","article-title":"Senolytics decrease senescent cells in humans: Preliminary report from a clinical trial of Dasatinib plus Quercetin in individuals with diabetic kidney disease","volume":"47","author":"Hickson","year":"2019","journal-title":"EBioMedicine"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1007581","article-title":"Bile salt hydrolases: Gatekeepers of bile acid metabolism and host-microbiome crosstalk in the gastrointestinal tract","volume":"15","author":"Foley","year":"2019","journal-title":"PloS Pathog"},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-024-07017-8","article-title":"Bile salt hydrolase acyltransferase activity expands bile acid diversity","volume":"626","author":"Guzior","year":"2024","journal-title":"Nature"},{"key":"B134","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-019-0504-5","article-title":"Healthspan and lifespan extension by fecal microbiota transplantation into progeroid mice","volume":"25","author":"B\u00e1rcena","year":"2019","journal-title":"Nat Med"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.3390\/nu14245200","article-title":"Impact of fecal microbiota transplantation on gut bacterial bile acid metabolism in humans","volume":"14","author":"Bustamante","year":"2022","journal-title":"Nutrients"},{"key":"B136","doi-asserted-by":"publisher","first-page":"e87","DOI":"10.1016\/j.clinthera.2023.11.015","article-title":"The effect of fecal microbiota transplantation on cardiometabolic risk factors: a systematic review and meta-analysis","volume":"46","author":"Pakmehr","year":"2024","journal-title":"Clin Ther"},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2019-320438","article-title":"Mediterranean diet intervention in overweight and obese subjects lowers plasma cholesterol and causes changes in the gut microbiome and metabolome independently of energy intake","volume":"69","author":"Meslier","year":"2020","journal-title":"Gut"},{"key":"B138","doi-asserted-by":"publisher","DOI":"10.1126\/science.aao5774","article-title":"Gut bacteria selectively promoted by dietary fibers alleviate type 2 diabetes","volume":"359","author":"Zhao","year":"2018","journal-title":"Science"},{"key":"B139","doi-asserted-by":"publisher","DOI":"10.3390\/nu11081826","article-title":"Effects of olive oil and its minor components on cardiovascular diseases, inflammation, and gut microbiota","volume":"11","author":"Marcelino","year":"2019","journal-title":"Nutrients"},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.1002\/med.21991","article-title":"FXR agonists for MASH therapy: Lessons and perspectives from obeticholic acid","volume":"44","author":"Wang","year":"2024","journal-title":"Med Res Rev"},{"key":"B141","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2021.06.012","article-title":"FXR activation protects against NAFLD via bile-acid-dependent reductions in lipid absorption","volume":"33","author":"Clifford","year":"2021","journal-title":"Cell Metab"},{"key":"B142","doi-asserted-by":"publisher","DOI":"10.2174\/0127724328239536230919070001","article-title":"A short review on obeticholic acid: an effective modulator of farnesoid x receptor","volume":"19","author":"Narayanan","year":"2024","journal-title":"Curr Rev Clin Exp Pharmacol Formerly Curr Clin Pharmacol"},{"key":"B143","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2011.11.006","article-title":"TGR5 activation inhibits atherosclerosis by reducing macrophage inflammation and lipid loading","volume":"14","author":"Pols","year":"2011","journal-title":"Cell Metab"},{"key":"B144","doi-asserted-by":"publisher","DOI":"10.1111\/sji.13361","article-title":"The role of bile acid receptor TGR5 in regulating inflammatory signalling","volume":"99","author":"Ye","year":"2024","journal-title":"Scand J Immunol"},{"key":"B145","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0108270","article-title":"Dual activation of the bile acid nuclear receptor FXR and G-protein-coupled receptor TGR5 protects mice against atherosclerosis","volume":"9","author":"Miyazaki-Anzai","year":"2014","journal-title":"PloS One"},{"key":"B146","doi-asserted-by":"publisher","DOI":"10.1111\/acel.13767","article-title":"Senolytic drugs, dasatinib and quercetin, attenuate adipose tissue inflammation, and ameliorate metabolic function in old age","volume":"22","author":"Islam","year":"2023","journal-title":"Aging Cell"},{"key":"B147","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/s10522-023-10068-5","article-title":"Quercetin and dasatinib, two powerful senolytics in age-related cardiovascular disease","volume":"25","author":"Nieto","year":"2024","journal-title":"Biogerontology"},{"key":"B148","doi-asserted-by":"publisher","DOI":"10.1172\/jci68815","article-title":"Metformin interferes with bile acid homeostasis through AMPK-FXR crosstalk","volume":"124","author":"Lien","year":"2014","journal-title":"J Clin Invest"},{"key":"B149","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-018-0222-4","article-title":"Gut microbiota and intestinal FXR mediate the clinical benefits of metformin","volume":"24","author":"Sun","year":"2018","journal-title":"Nat Med"},{"key":"B150","doi-asserted-by":"publisher","DOI":"10.1038\/nm.4345","article-title":"Metformin alters the gut microbiome of individuals with treatment-naive type 2 diabetes, contributing to the therapeutic effects of the drug","volume":"23","author":"Wu","year":"2017","journal-title":"Nat Med"},{"key":"B151","doi-asserted-by":"publisher","DOI":"10.1210\/endrev\/bnad029","article-title":"Metformin, cognitive function, and changes in the gut microbiome","volume":"45","author":"Rosell-D\u00edaz","year":"2024","journal-title":"Endocr Rev"},{"key":"B152","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2016.05.011","article-title":"Metformin as a tool to target aging","volume":"23","author":"Barzilai","year":"2016","journal-title":"Cell Metab"},{"key":"B153","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2014.12.034","article-title":"Ursodeoxycholic acid exerts farnesoid X receptor-antagonistic effects on bile acid and lipid metabolism in morbid obesity","volume":"62","author":"Mueller","year":"2015","journal-title":"J Hepatol"},{"key":"B154","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1002\/hep.30145","article-title":"Primary biliary cholangitis: 2018 practice guidance from the American Association for the Study of Liver Diseases","volume":"69","author":"Lindor","year":"2019","journal-title":"Hepatology"},{"key":"B155","doi-asserted-by":"publisher","DOI":"10.1021\/acs.analchem.5b01556","article-title":"Bile acid profiling and quantification in biofluids using ultra-performance liquid chromatography tandem mass spectrometry","volume":"87","author":"Sarafian","year":"2015","journal-title":"Anal Chem"},{"key":"B156","doi-asserted-by":"publisher","DOI":"10.1210\/er.2018-00134","article-title":"Fibroblast growth factor 15\/19: from basic functions to therapeutic perspectives","volume":"39","author":"Somm","year":"2018","journal-title":"Endocr Rev"},{"key":"B157","doi-asserted-by":"publisher","DOI":"10.1080\/13543784.2020.1763302","article-title":"Bile acid modulators for the treatment of nonalcoholic steatohepatitis (NASH)","volume":"29","author":"Fiorucci","year":"2020","journal-title":"Expert Opin Invest Drugs"},{"key":"B158","doi-asserted-by":"publisher","DOI":"10.1038\/s42255-022-00559-z","article-title":"Metabolic messengers: bile acids","volume":"4","author":"Perino","year":"2022","journal-title":"Nat Metab"},{"key":"B159","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2023.2290331","article-title":"Targeting gut microbiota in aging-related cardiovascular dysfunction: focus on the mechanisms","volume":"15","author":"Liu","year":"2023","journal-title":"Gut Microbes"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1870980\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T04:21:12Z","timestamp":1783311672000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1870980\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,6]]},"references-count":159,"alternative-id":["10.3389\/fimmu.2026.1870980"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1870980","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,6]]},"article-number":"1870980"}}